Patents by Inventor Hamdi K. Hamdi

Hamdi K. Hamdi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7468355
    Abstract: Methods for inhibiting cancer, scar formation, disrupting the cellular cytoskeleton, and conferring resistance from infection are disclosed. Such methods comprise the administration of oleuropein and/or the products of its hydrolysis in therapeutically effective amounts. To that end, a variety of pharmaceutical formulations and routes or administration are disclosed and may be utilized to treat a wide variety of diseases.
    Type: Grant
    Filed: November 13, 2003
    Date of Patent: December 23, 2008
    Assignee: H2RC Corporation
    Inventors: Hamdi K. Hamdi, Raquel Castellon
  • Publication number: 20040097428
    Abstract: Methods for inhibiting cancer, scar formation, disrupting the cellular cytoskeleton, and conferring resistance from infection are disclosed. Such methods comprise the administration of oleuropein and/or the products of its hydrolysis in therapeutically effective amounts. To that end, a variety of pharmaceutical formulations and routes or administration are disclosed and may be utilized to treat a wide variety of diseases.
    Type: Application
    Filed: November 13, 2003
    Publication date: May 20, 2004
    Inventors: Hamdi K. Hamdi, Raquel Castellon
  • Publication number: 20040048808
    Abstract: Methods for inhibiting angiogensis are disclosed the comprise administering oleouropein and/or the products of its hydrolysis in therapeutically effective amounts. The methods and compositions of the present invention are particularly effective in inhibiting the vascularization of endothelial cells, and may be utilized to treat a wide variety of cancers, ocular diseases, and inflammatory conditions.
    Type: Application
    Filed: September 8, 2003
    Publication date: March 11, 2004
    Inventors: Hamdi K. Hamdi, Jeffrey H. Tavis, Raquel Castellon
  • Patent number: 6632798
    Abstract: Methods for inhibiting angiogenisis are disclosed the comprise administering oleouropein and/or the products of its hydrolysis in therapeutically effective amounts. The methods and compositions of the present invention are particularly effective in inhibiting the vascularization of endothelial cells, and may be utilized to treat a wide variety of cancers, ocular diseases, and inflammatory conditions.
    Type: Grant
    Filed: May 22, 2002
    Date of Patent: October 14, 2003
    Assignee: Antigen Biologicals Corporation
    Inventors: Hamdi K. Hamdi, Jeffrey H. Tavis, Raquel Castellon
  • Publication number: 20030004117
    Abstract: Methods for inhibiting angiogensis are disclosed the comprise administering oleouropein and/or the products of its hydrolysis in therapeutically effective amounts. The methods and compositions of the present invention are particularly effective in inhibiting the vascularization of endothelial cells, and may be utilized to treat a wide variety of cancers, ocular diseases, and inflammatory conditions.
    Type: Application
    Filed: May 22, 2002
    Publication date: January 2, 2003
    Inventors: Hamdi K. Hamdi, Jeffrey H. Tavis, Raquel Castellon